Is there a vaccine against RSV? After nearly 60 years, many potential candidates came at the same time

Published Date: 02 Mar 2023

You may not have heard of respiratory syncytial virus (RSV). However, it killed more than 100,000 people worldwide in 2019, making it the leading cause of death among children under the age of one.

Read Full News

Latest News

Cancer Recurrence: What Awakens Dormant Tumor Cells?

Emerging therapies target dormant tumor cells and their microenvironment to delay or prevent metastatic recurrence after successful cancer treatment.

Autoimmune Diseases Respond to Teclistamab but With Risks

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

Expanded Pediatric Use for Roflumilast Under FDA Review

If approved, topical roflumilast 0.05% will be approved for treating atopic dermatitis down to age 3 months.

Model Spots Kids With Anaphylaxis Who Do Not Require ED Care

A prediction model identifies children with anaphylaxis who are at a low risk of requiring additional epinephrine and may safely avoid visits to the emergency department.

What's Really Killing Patients With Late-Stage PD?

A decade-long study finds aspiration pneumonia as the leading cause of death in late-stage Parkinson's disease, and worsening motor function, cognition, and depression predict a higher risk for death.

Lower Breathing Pressure Tied to Complications in Preemies

In premature babies, lower breathing pressure at birth is linked to a higher likelihood of needing a breathing tube and later lung and eye complications.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Latest News

Emerging therapies target dormant tumor cells and their microenvironment to delay or prevent metastatic recurrence after successful cancer treatment.

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

If approved, topical roflumilast 0.05% will be approved for treating atopic dermatitis down to age 3 months.

A prediction model identifies children with anaphylaxis who are at a low risk of requiring additional epinephrine and may safely avoid visits to the emergency department.

A decade-long study finds aspiration pneumonia as the leading cause of death in late-stage Parkinson's disease, and worsening motor function, cognition, and depression predict a higher risk for death.

In premature babies, lower breathing pressure at birth is linked to a higher likelihood of needing a breathing tube and later lung and eye complications.

News All Time

Limited Data for JAK Inhibitors in SSc Described in Study

In patients with systemic sclerosis, JAK inhibitors show comparable effectiveness to standard immunosuppressants, but many stop therapy due to treatment failure or adverse events.

Abrocitinib Boosts Skin Clearance and Itch Relief in AD

Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to dupilumab, a post hoc study shows.

When Patients Arrive With AI Diagnoses

Patients increasingly come to visits with AI-generated ideas and online research, forcing doctors to balance information, uncertainty, and reassurance in real time.

When Patient Self-Scheduling Collides With Acute Care

Many health systems are giving patients the power to schedule appointments and procedures. What happens when that autonomy creates down-stream problems?

Hydrolyzed Rice Formula Effective in Cow’s Milk Allergy

Hydrolyzed rice formula serves as an additional nutritional option for managing cow’s milk protein allergy in infants.

Which Medications Increase Heat-Related Risk in Patients?

During periods of extreme heat, several drug classes can make patients more vulnerable to dehydration, heat exhaustion, and heatstroke.

Maternal RSV Shot Largely Safe, Except for Hypertension Risk

Vaccination against respiratory syncytial virus given late in pregnancy is not linked to adverse birth outcomes but is linked to a slightly increased risk for hypertensive disorders of pregnancy.

US FDA Approves Vera's Kidney Disease Drug

The U.S. Food and Drug Administration said on Tuesday it had approved Vera Therapeutics' drug to treat ⁠patients with a potentially life-threatening kidney...

Online Care Equals In-Person for Atopic Dermatitis QOL

An online team-based teledermatology model provides quality-of-life improvements equivalent to in-person care, according to the results of a randomized trial.

Advances in Pulmonary Arterial Hypertension: Optimizing Care With the Latest Guidelines and Treatment Approaches

Advances in Pulmonary Arterial Hypertension: Optimizing Care With the Latest Guidelines and Treatment Approaches

Hantavirus Webinar May 12: What You Need to Know

Join us for a live conversation about the evolving cruise ship outbreak

Big Gaps Between Heart Failure Patients' Goals and Clinical Reality, Survey Reveals

Many prioritize comfort but also want intensive therapies

Endovascular Thrombectomy Boosts Outcomes in Medium-Vessel Ischemic Stroke

Chinese randomized trial shows "meaningful improvement" in functional outcomes

Nurse Tortured, Prosecutors Say; Hantavirus Case Critically Ill; Skin Cream Recall

Health news and commentary gathered by MedPage Today staff

Exercise and Blood Pressure; Maternal Occupation and Autism

Also in TTHealthWatch: digoxin for heart failure

Novel Central Line Locking Fluid Reduces Certain Complications in ICU

How clinically meaningful the impact of randomized trial findings is debatable

Recommended News For You

For treatment, the majority of cancer patients choose complementary therapies.

What is Mohs micrographic surgery? 8 FAQs about Mohs

Measurable Residual Disease Predicts Real-World AML Relapse

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

CAR T cells improve patients' quality of life: a study

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

Recommended Articles For You

Quality of Life Optimization in Long-Term Cancer Survivorship 

Everything You Need to Know About Leiomyomas: A Comprehensive Guide  

Exploring the Causes and Treatment of Granulocytopenia: A Comprehensive Guide 

The Role of Alanine Aminotransferase in Liver Health and Disease  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer

2.

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

3.

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

4.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

5.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

1.

Surprising Symptoms of Prostate Cancer: What You Need to Know

2.

How EPCORITAMAB is Revolutionizing the Treatment of Cancer

3.

AI in Genomics: Decoding the Human Genome for Cancer Treatment

4.

Immune Escape Landscapes in Solid Tumors

5.

Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Updates on Standard V/S High Risk Myeloma Treatment- The Next Part

3.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

5.

Navigating the Complexities of Ph Negative ALL - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot